Understanding and Managing Recurrent Prostate Cancer
June 17, 2019
A Diagnostic Imaging Test That May Detect and Localize Recurrent Prostate Cancer
There’s big decisions to be made for patients living with recurrent prostate cancer, from what’s next to treatment options, recurrence management, and more.
However, in the management of recurrent prostate cancer, conventional imaging (bone scans, CT, and MRI) have limitations.
Newer PET/CT imaging techniques can provide physicians and patients living with prostate cancer an opportunity to detect and localize recurrent disease at a much lower PSA level than conventional imaging.
The information provided by this type of PET/CT imaging may provide an opportunity for more personalized disease management.
Stay tuned as Dr. Jonathan K. Jay and his patient Peter Irving share the importance of knowing your options in the ongoing monitoring and management of recurrent prostate cancer.
Don’t move! The Balancing Act is back with a new Behind the Mystery segment and an inside look at a Broadway sensation.
We're discussing Alport syndrome, a rare, genetic, and chronic kidney condition characterized by declining kidney function which can lead to end-stage kidney disease.
When it comes to facial and body rejuvenation, discover a patient-first, non-surgical approach at Jupiter Plastic Surgery Center.